Skip to content

"The protective effect of nano curcumin supplementation on doxorubicin induced cardiotoxicity in breast cancer patients; a randomized, double-blind clinical trial".

Randomized controlled trial · J Oncol Pharm Pract · 2025. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 39223927

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

"The protective effect of nano curcumin supplementation on doxorubicin induced cardiotoxicity in breast cancer patients; a randomized, double-blind clinical trial".

Tohidi M, Allahyari A, Ataei Azimi S et al.
J Oncol Pharm Pract · 2025

PubMed ID
39223927
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.